Literature DB >> 34169837

Evolution of fibroblasts in the lung metastatic microenvironment is driven by stage-specific transcriptional plasticity.

Ophir Shani1, Yael Raz1, Lea Monteran1, Ye'ela Scharff1, Oshrat Levi-Galibov2, Or Megides3, Hila Shacham3, Noam Cohen1, Dana Silverbush4, Camilla Avivi5, Roded Sharan6, Asaf Madi1, Ruth Scherz-Shouval2, Iris Barshack5, Ilan Tsarfaty3, Neta Erez1.   

Abstract

Mortality from breast cancer is almost exclusively a result of tumor metastasis, and lungs are one of the main metastatic sites. Cancer-associated fibroblasts (CAFs) are prominent players in the microenvironment of breast cancer. However, their role in the metastatic niche is largely unknown. In this study, we profiled the transcriptional co-evolution of lung fibroblasts isolated from transgenic mice at defined stage-specific time points of metastases formation. Employing multiple knowledge-based platforms of data analysis provided powerful insights on functional and temporal regulation of the transcriptome of fibroblasts. We demonstrate that fibroblasts in lung metastases are transcriptionally dynamic and plastic, and reveal stage-specific gene signatures that imply functional tasks, including extracellular matrix remodeling, stress response and shaping the inflammatory microenvironment. Furthermore, we identified Myc as a central regulator of fibroblast rewiring and found that stromal upregulation of Myc transcriptional networks is associated with disease progression in human breast cancer.
© 2021, Shani et al.

Entities:  

Keywords:  cancer biology; mouse

Year:  2021        PMID: 34169837     DOI: 10.7554/eLife.60745

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  7 in total

1.  Possible Metastatic Stage-Dependent ILC2 Activation Induces Differential Functions of MDSCs through IL-13/IL-13Rα1 Signaling during the Progression of Breast Cancer Lung Metastasis.

Authors:  Atsushi Ito; Yuichi Akama; Naoko Satoh-Takayama; Kanako Saito; Takuma Kato; Eiji Kawamoto; Arong Gaowa; Eun Jeong Park; Motoshi Takao; Motomu Shimaoka
Journal:  Cancers (Basel)       Date:  2022-07-04       Impact factor: 6.575

2.  Fibroblast-Derived IL33 Facilitates Breast Cancer Metastasis by Modifying the Immune Microenvironment and Driving Type 2 Immunity.

Authors:  Ophir Shani; Tatiana Vorobyov; Lea Monteran; Dor Lavie; Noam Cohen; Yael Raz; Galia Tsarfaty; Camila Avivi; Iris Barshack; Neta Erez
Journal:  Cancer Res       Date:  2020-10-06       Impact factor: 12.701

3.  Fibroblast-mediated uncaging of cancer cells and dynamic evolution of the physical microenvironment.

Authors:  Chang Liu; Michael Mak
Journal:  Sci Rep       Date:  2022-01-17       Impact factor: 4.379

Review 4.  Propensity for Early Metastatic Spread in Breast Cancer: Role of Tumor Vascularization Features and Tumor Immune Infiltrate.

Authors:  Mario Rosario D'Andrea; Vittore Cereda; Luigi Coppola; Guido Giordano; Andrea Remo; Elena De Santis
Journal:  Cancers (Basel)       Date:  2021-11-25       Impact factor: 6.639

5.  Dynamic Changes in Myofibroblasts Affect the Carcinogenesis and Prognosis of Bladder Cancer Associated With Tumor Microenvironment Remodeling.

Authors:  YiHeng Du; YiQun Sui; Jin Cao; Xiang Jiang; Yi Wang; Jiang Yu; Bo Wang; XiZhi Wang; BoXin Xue
Journal:  Front Cell Dev Biol       Date:  2022-03-02

6.  Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer.

Authors:  Lea Monteran; Nour Ershaid; Hila Doron; Yael Zait; Ye'ela Scharff; Shahar Ben-Yosef; Camila Avivi; Iris Barshack; Amir Sonnenblick; Neta Erez
Journal:  Nat Commun       Date:  2022-10-02       Impact factor: 17.694

Review 7.  CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion.

Authors:  Gurcan Gunaydin
Journal:  Front Oncol       Date:  2021-07-14       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.